Publications

Hartner, A.-M., Li, X., Echeverria-Londono, S., Roth, J., Abbas, K., Auzenbergs, M., De Villiers, M. J., Ferrari, M. J., Fraser, K., Fu, H., Hallett, T., Hinsley, W., Jit, M., Karachaliou, A., Moore, S. M., Nayagam, S., Papadopoulos, T., Perkins, T. A., Portnoy, A., … Gaythorpe, K. A. M. (2024). Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study. The Lancet Global Health, 12(4), e563–e571. https://doi.org/10.1016/S2214-109X(23)00603-4 Cite

Kang, H., Auzenbergs, M., Clapham, H., Maure, C., Kim, J.-H., Salje, H., Taylor, C. G., Lim, A., Clark, A., Edmunds, W. J., Sahastrabuddhe, S., Brady, O. J., & Abbas, K. (2024). Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. The Lancet Infectious Diseases, S1473309923008101. https://doi.org/10.1016/S1473-3099(23)00810-1 Cite

Auzenbergs, M., Maure, C., Kang, H., Clark, A., Brady, O., Sahastrabuddhe, S., & Abbas, K. (2024). Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis. PLOS Neglected Tropical Diseases, 18(4), e0012075. https://doi.org/10.1371/journal.pntd.0012075 Cite

Williams, S. V., Akande, T., & Abbas, K. (2024). Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria. PLOS ONE, 19(3), e0297326. https://doi.org/10.1371/journal.pone.0297326 Cite

Abbas, K., Yoo, K. J., Prem, K., & Jit, M. (2024). Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010–22: a modelling study. EClinicalMedicine, 102524. https://doi.org/10.1016/j.eclinm.2024.102524 Cite

Ngwe Tun, M. M., Kyaw, A. K., Nwe, K. M., Myaing, S. S., Win, Y. T., Inoue, S., Takamatsu, Y., Urano, T., Thu, H. M., Hmone, S. W., Thant, K. Z., & Morita, K. (2023). Burden of Chikungunya Virus Infection during an Outbreak in Myanmar. Viruses, 15(8), 1734. https://doi.org/10.3390/v15081734 Cite

Balingit, J. C., Dimamay, M. P. S., Suzuki, R., Matsuda, M., Xayavong, D., Ngwe Tun, M. M., Matias, R. R., Natividad, F. F., Moi, M. L., Takamatsu, Y., Culleton, R., Buerano, C. C., & Morita, K. (2024). Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data. International Journal of Infectious Diseases, 139, 59–68. https://doi.org/10.1016/j.ijid.2023.11.025 Cite

Paul, K. M. M., Simpson, S. V., Nundu, S. S., Arima, H., & Yamamoto, T. (2024). Genetic diversity of glutamate-rich protein (GLURP) in Plasmodium falciparum isolates from school-age children in Kinshasa, DRC. Parasitology International, 100, 102866. https://doi.org/10.1016/j.parint.2024.102866 Cite

Mogasale, V., Sinha, A., John, J., Farooqui, H., Ray, A., Chantler, T., Mogasale, V., Dhoubhadel, B. G., Edmunds, W. J., Clark, A. D., & Abbas, K. (2024). Research Priorities to Support Typhoid Conjugate Vaccine Decision-Making in India: Evidence Assessment and Stakeholder Survey (SSRN Scholarly Paper 4714399). https://doi.org/10.2139/ssrn.4714399 Cite

Parajulee, P., Lee, J.-S., Abbas, K., Cannon, J., Excler, J. L., Kim, J. H., & Mogasale, V. (2024). State transitions across the Strep A disease spectrum: scoping review and evidence gaps. BMC Infectious Diseases, 24(1), 108. https://doi.org/10.1186/s12879-023-08888-4 Cite

Naylor, N. R., Hasso-Agopsowicz, M., Kim, C., Ma, Y., Frost, I., Abbas, K., Aguilar, G., Fuller, N. M., Robotham, J. V., & Jit, M. (2023). The Global Economic Burden of Antibiotic Resistant Infections and the Potential Impact of Bacterial Vaccines: A Modelling Study (SSRN Scholarly Paper 4676946). https://doi.org/10.2139/ssrn.4676946 Cite

Murayama, H., Endo, A., & Yonekura, S. (2023). Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics. Epidemics, 45, 100726. https://doi.org/10.1016/j.epidem.2023.100726 Cite

Ngwe Tun, M. M., Raini, S. K., Fernando, L., Gunawardene, Y., Inoue, S., Takamatsu, Y., Urano, T., Muthugala, R., Hapugoda, M., & Morita, K. (2023). Epidemiological evidence of acute transmission of Zika virus infection in dengue suspected patients in Sri-Lanka. Journal of Infection and Public Health, 16(9), 1435–1442. https://doi.org/10.1016/j.jiph.2023.07.014 Cite

Nwe, K. M., Tun, M. M. N., Muthugala, R., Nabeshima, T., Balingit, J. C., Rajamanthri, L., Jayawardana, D., Attanayake, S., Inoue, S., Takamatsu, Y., Urano, T., & Morita, K. (2023). Clinical, Virological, and Immunological Features in Cosmopolitan Genotype DENV-2–Infected Patients during a Large Dengue Outbreak in Sri Lanka in 2017. The American Journal of Tropical Medicine and Hygiene, 109(4), 917–925. https://doi.org/10.4269/ajtmh.22-0780 Cite

Ngwe Tun, M. M., Nwe, K. M., Balingit, J. C., Takamatsu, Y., Inoue, S., Pandey, B. D., Urano, T., Kohara, M., Tsukiyama-Kohara, K., & Morita, K. (2023). A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis. Vaccines, 11(12), 1857. https://doi.org/10.3390/vaccines11121857 Cite

Furuse, Y. (2024). Characteristics of retracted research papers before and during the COVID-19 pandemic. Frontiers in Medicine, 10. https://www.frontiersin.org/articles/10.3389/fmed.2023.1288014 Cite

Yoshikawa, R., Kawakami, M., & Yasuda, J. (2023). The NSs protein of severe fever with thrombocytopenia syndrome virus differentially inhibits the type 1 interferon response among animal species. Journal of Biological Chemistry, 299(6), 104819. https://doi.org/10.1016/j.jbc.2023.104819 Cite

Nabeshima, T., Ngwe Tun, M. M., Thuy, N. T. T., Hang, N. L. K., Mai, L. T. Q., Hasebe, F., Takamatsu, Y., & Nagasaki University Vietnam Research Group. (2023). An outbreak of a novel lineage of dengue virus 2 in Vietnam in 2022. Journal of Medical Virology, 95(11), e29255. https://doi.org/10.1002/jmv.29255 Cite

Fu, H., Abbas, K., Malvolti, S., Gregory, C., Ko, M., Amorij, J.-P., & Jit, M. (2023). Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation. BMJ Global Health, 8(11), e012204. https://doi.org/10.1136/bmjgh-2023-012204 Cite

Flandes, X., Hansen, C. A., Palani, S., Abbas, K., Bennett, C., Caro, W. P., Hutubessy, R., Khazhidinov, K., Lambach, P., Maure, C., Marshall, C., Rojas, D. P., Rosewell, A., Sahastrabuddhe, S., Tufet, M., Wilder-Smith, A., Beasley, D. W. C., Bourne, N., & Barrett, A. D. T. (2023). Vaccine value profile for Chikungunya. Vaccine. https://doi.org/10.1016/j.vaccine.2023.07.069 Cite

Qian, G. Y., Edmunds, W. J., Bausch, D. G., & Jombart, T. (2023). A mathematical model of Marburg virus disease outbreaks and the potential role of vaccination in control. BMC Medicine, 21(1), 439. https://doi.org/10.1186/s12916-023-03108-x Cite

Furuse, Y. (2023). Estimation of excess cardiovascular deaths after COVID-19 in 2020. The Journal of Infection, 87(1), e5–e7. https://doi.org/10.1016/j.jinf.2023.04.014 Cite

Ngwe Tun, M. M., Kyaw, A. K., Nabeshima, T., Dumre, S. P., Soe, A. M., Nwe, K. M., Myaing, S. S., Lwin, E. P., Win, Y. T., Inoue, S., Takamatsu, Y., Urano, T., Thu, H. M., Thant, K. Z., Htun, Z. T., & Morita, K. (2023). Coinfection and circulation of chikungunya virus and dengue virus in pediatric patients in Myanmar, 2019. Microbes and Infection, 25(6), 105129. https://doi.org/10.1016/j.micinf.2023.105129 Cite

Rimal, S., Shrestha, S., Pandey, K., Nguyen, T. V., Bhandari, P., Shah, Y., Acharya, D., Adhikari, N., Rijal, K. R., Ghimire, P., Takamatsu, Y., Pandey, B. D., Fernandez, S., Morita, K., Ngwe Tun, M. M., & Dumre, S. P. (2023). Co-Circulation of Dengue Virus Serotypes 1, 2, and 3 during the 2022 Dengue Outbreak in Nepal: A Cross-Sectional Study. Viruses, 15(2), 507. https://doi.org/10.3390/v15020507 Cite

Furuse, Y. (2023). Cartography of SARS-CoV-2 variants based on the susceptibility to therapeutic monoclonal antibodies. Journal of Medical Virology, 95(1), e28275. https://doi.org/10.1002/jmv.28275 Cite

Qian, G. Y., Jombart, T., & John Edmunds, W. (2023). Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: A modelling study. Vaccine: X, 14, 100321. https://doi.org/10.1016/j.jvacx.2023.100321 Cite

Qian, G. Y., Jombart, T., & Edmunds, W. J. (2023). Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: a modelling study. medRxiv. https://doi.org/10.1101/2023.02.22.23286294 Cite

Nguyen, T. V., Ngwe Tun, M. M., Cao, M. T., Dao, H. M., Luong, C. Q., Huynh, T. K. L., Nguyen, T. T. T., Hoang, T. N. D., Morita, K., Le, T. Q. M., Pham, Q. D., Takamatsu, Y., & Hasebe, F. (2023). Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017-2019. Viruses, 15(10), 2065. https://doi.org/10.3390/v15102065 Cite

Cadarette, D., Ferranna, M., Cannon, J. W., Abbas, K., Giannini, F., Zucker, L., & Bloom, D. E. (2023). The full health, economic, and social benefits of prospective Strep A vaccination. Npj Vaccines, 8(1), 1–9. https://doi.org/10.1038/s41541-023-00758-z Cite